Cargando…
The role of biological dose-escalation for pancreatic cancer
The role of chemo-radiotherapy for treatment of locally advanced pancreatic cancer (LAPC) has been discussed for many years, and the absence of an overall survival benefit compared to gemcitabine chemotherapy alone in the recent LAP07 study seems to have increased the controversy. However, even in t...
Autores principales: | Bruynzeel, Anna M.E., Lagerwaard, Frank J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630149/ https://www.ncbi.nlm.nih.gov/pubmed/31341988 http://dx.doi.org/10.1016/j.ctro.2019.04.020 |
Ejemplares similares
-
Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer
por: Tetar, Shyama U., et al.
Publicado: (2019) -
De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation
por: Thomas, Pepijn W. A., et al.
Publicado: (2022) -
Magnetic resonance imaging-guided radiotherapy for intermediate- and high-risk prostate cancer: Trade-off between planning target volume margin and online plan adaption
por: Tetar, Shyama U., et al.
Publicado: (2022) -
Pitfalls of Ovarian Ablative Magnetic Resonance-guided Radiation Therapy for Refractory Endometriosis
por: Tetar, Shyama, et al.
Publicado: (2018) -
Combined Inter- and Intrafractional Plan Adaptation Using Fraction Partitioning in Magnetic Resonance-guided Radiotherapy Delivery
por: Lagerwaard, Frank, et al.
Publicado: (2018)